Literature DB >> 26855498

Carbohydrate Deficient Transferrin and Interleukin-6 as Predictors of Fibrosis in Alcohol Cirrhosis.

Hanumanthappa Nandeesha1, Medha Rajappa1, Tamilarasu Kadhiravan2, Krishnamoorthy Srilatha1, Kottyen Thazhath Harichandrakumar3, Durgadevi Thyagarajan1.   

Abstract

The severity of alcoholic cirrhosis depends on the presence of liver inflammation and fibrogenesis. Previous studies have hypothesized that carbohydrate deficient transferrin can be used as marker of liver impairment in alcoholic liver disease patients. The present study was designed to assess whether carbohydrate deficient transferrin is associated with procollagen III peptide and predict fibrosis in alcohol cirrhosis patients. We enrolled 48 patients with alcoholic cirrhosis and 38 healthy controls. Serum carbohydrate deficient transferrin, procollagen III peptide and interleukin-6 levels were estimated in both groups. Serum carbohydrate deficient transferrin, procollagen III peptide and interleukin-6 were significantly increased in alcoholic cirrhosis patients compared to controls. Stepwise regression analysis showed that carbohydrate deficient transferrin (adjusted R(2) = 0.313, β = 0.362, p = 0.003) and interleukin-6 (adjusted R(2) = 0.194, β = 0.459, p = 0.001) were positively associated with procollagen III peptide when age, duration and amount of alcohol consumption were considered as covariates. We conclude that elevated carbohydrate deficient transferrin and interleukin-6 act as predictors of fibrosis in alcoholic cirrhosis.

Entities:  

Keywords:  Carbohydrate deficient transferrin; Fibrogenesis; Inflammation; Interleukin-6; Procollagen III peptide

Year:  2015        PMID: 26855498      PMCID: PMC4731361          DOI: 10.1007/s12291-015-0534-9

Source DB:  PubMed          Journal:  Indian J Clin Biochem        ISSN: 0970-1915


  19 in total

1.  Serum type I collagen and N-terminal peptide of type III procollagen in patients with alcoholic liver disease: relationship to liver histology.

Authors:  J C Trinchet; D J Hartmann; D Pateron; C Munz-Gotheil; P Callard; G Ville; M Beaugrand
Journal:  Alcohol Clin Exp Res       Date:  1992-04       Impact factor: 3.455

2.  IL-6-deficient mice are susceptible to ethanol-induced hepatic steatosis: IL-6 protects against ethanol-induced oxidative stress and mitochondrial permeability transition in the liver.

Authors:  Osama El-Assal; Feng Hong; Won-Ho Kim; Svetlana Radaeva; Bin Gao
Journal:  Cell Mol Immunol       Date:  2004-06       Impact factor: 11.530

3.  Serum procollagen type III peptide as a marker of hepatic fibrogenesis in alcoholic hepatitis.

Authors:  M Torres-Salinas; A Parés; J Caballería; W Jiménez; D Heredia; M Bruguera; J Rodés
Journal:  Gastroenterology       Date:  1986-05       Impact factor: 22.682

Review 4.  The model for end-stage liver disease (MELD).

Authors:  Patrick S Kamath; W Ray Kim
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

5.  [Serum interleukin-6 concentrations in patients with alcoholic liver disease].

Authors:  Renata Swiatkowska-Stodulska; Alicja Bakowska
Journal:  Pol Merkur Lekarski       Date:  2004-09

Review 6.  Molecular basis and current treatment for alcoholic liver disease.

Authors:  Alejandra Miranda-Mendez; Alejandro Lugo-Baruqui; Juan Armendariz-Borunda
Journal:  Int J Environ Res Public Health       Date:  2010-04-27       Impact factor: 3.390

7.  Diagnostic characteristics of different carbohydrate-deficient transferrin methods in the detection of problem drinking: effects of liver disease and alcohol consumption.

Authors:  Petra Anttila; Kimmo Järvi; Jaana Latvala; Joan E Blake; Onni Niemelä
Journal:  Alcohol Alcohol       Date:  2003 Sep-Oct       Impact factor: 2.826

8.  [Identification of elevated carbohydrate-deficient transferrin (CDT) serum level as transferrin (Tf)-D-variant by means of isoelectric focusing].

Authors:  M W Welker; H Printz; R Hackler; M Rafat; A Helwig-Rolig; J R Schäfer; B Simon
Journal:  Z Gastroenterol       Date:  2004-09       Impact factor: 2.000

Review 9.  Biochemical markers of hepatic fibrosis.

Authors:  M Plebani; A Burlina
Journal:  Clin Biochem       Date:  1991-06       Impact factor: 3.281

Review 10.  Biomarkers of liver fibrosis: clinical translation of molecular pathogenesis or based on liver-dependent malfunction tests.

Authors:  Olav A Gressner; Ralf Weiskirchen; Axel M Gressner
Journal:  Clin Chim Acta       Date:  2007-02-27       Impact factor: 3.786

View more
  1 in total

1.  Use of Filter Paper to Measure Alcohol Biomarkers among Opioid-Dependent Patients on Agonist Maintenance Treatment: A Community-Based Study.

Authors:  Rizwana Quraishi; Mohit Varshney; Amit Singh; Dharamveer Singh; Mukesh Kumar; Ravindra Rao; Raka Jain; Atul Ambekar
Journal:  Indian J Psychol Med       Date:  2019-11-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.